Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Here we are again

<< Previous

Bullboard Posts

Next >>

Comment by zombizeon Nov 07, 2024 8:57am

155 Views

Post# 36300639

RE:RE:RE:Here we are again

Point taken, poor use of the word 'rejected' - but, my point remains; wouldn't any response regarding pre-BTD recommendations that led to a signfiicant delay in the formal BTD application be, in itself, a material development? To paraphrase you, I don't think Theralase is obliged to report every single snag to it's shareholders, but, as regards pre-BTD/BTD, I'm sort of of the opinion that no news is good news until we hopefully get the really good news.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity